Rep. Robert P. Bresnahan, Jr. bought Bio-Techne (TECH)
Rep. Robert P. Bresnahan, Jr. (R-PA-8) · $1K–$15K · traded Feb 25, 2025
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Feb 25, 2025
- Disclosed
- Mar 27, 2025
- Days to disclose
- 30
- Asset type
- Stock
- As filed
- Bio-Techne Corp - Common Stock
- Industry
- Biotechnology · Healthcare
Other trades in this filing
All of Bresnahan's trades →- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Mar 7, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
Sold Credo Technology Group Holding CRDO
$1K–$15K · Traded Mar 6, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Mar 6, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Mar 5, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Mar 4, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Mar 4, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Mar 4, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$15K–$50K
Sold Alibaba Group Holding Limited BABA
$15K–$50K · Traded Mar 4, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
Sold Credo Technology Group Holding CRDO
$1K–$15K · Traded Mar 4, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
Bought Take-Two Interactive Software TTWO
$1K–$15K · Traded Mar 3, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Mar 3, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
Bought Alibaba Group Holding Limited BABA
$1K–$15K · Traded Mar 3, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
Sold Taiwan Semiconductor Manufacturing Company Limited TSM
$1K–$15K · Traded Mar 3, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Mar 3, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Mar 3, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Feb 27, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Feb 27, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
Sold Astera Labs, Inc. Common Stock ALAB
$1K–$15K · Traded Feb 27, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Feb 26, 2025 · disclosed Mar 27, 2025
- Mar 27, 2025$1K–$15K
$1K–$15K · Traded Feb 26, 2025 · disclosed Mar 27, 2025
Recent Congress trades in TECH
- May 6, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Apr 8, 2026 · disclosed May 6, 2026 · Dependent
- Apr 6, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
Sold (partial) Bio-Techne TECH
$1K–$15K · Traded Mar 26, 2026 · disclosed Apr 6, 2026 · Dependent
- Mar 10, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
Sold (partial) Bio-Techne TECH
$1K–$15K · Traded Feb 24, 2026 · disclosed Mar 10, 2026 · Dependent
- Feb 2, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
Sold (partial) Bio-Techne TECH
$1K–$15K · Traded Jan 28, 2026 · disclosed Feb 2, 2026 · Dependent
- Jan 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Dec 5, 2025 · disclosed Jan 5, 2026 · Dependent
- Jan 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Dec 2, 2025 · disclosed Jan 5, 2026 · Dependent
- Nov 4, 2025$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Oct 22, 2025 · disclosed Nov 4, 2025 · Dependent
- Sep 2, 2025$1K–$15K
Rep. April McClain Delaney (D-MD-6)
Sold (partial) Bio-Techne TECH
$1K–$15K · Traded Aug 1, 2025 · disclosed Sep 2, 2025 · Dependent
Company context for TECH
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
TECH: amended insider filing
An amended ownership report was filed. Read the original and amendment before comparing transactions.
TECH: amended insider filing
An amended ownership report was filed. Read the original and amendment before comparing transactions.
TECH: amended insider filing
An amended ownership report was filed. Read the original and amendment before comparing transactions.
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.